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Abstract
Background: The control of tick and flea burdens in dogs and cats has become essential to the control of
important and emerging vector borne diseases, some of which are zoonoses. Flea worry and flea bite
hypersensitivity are additionally a significant disease entity in dogs and cats. Owner compliance in maintaining the
pressure of control measures has been shown to be poor. For these reasons efforts are continuously being made
to develop ectoparasiticides and application methods that are safe, effective and easy to apply for pet owners. A
new polymer matrix collar has recently been developed which is registered for 8 months use in cats and dogs. The
basic properties of this collar have been investigated in several in vitro and in vivo studies.
Methods: The effects of imidacloprid, flumethrin and the combination were evaluated in vitro by means of whole
cell voltage clamp measurement experiments conducted on isolated neuron cells from Spodoptera frugiperda. The
in vitro efficacy of the two compounds and the combination against three species of ticks and their life stages and
fleas were evaluated in a dry surface glass vial assay. The kinetics of the compounds over time in the collar were
evaluated by the change in mass of the collar and measurement of the surface concentrations and concentrations
of the actives in the collar matrix by HPLC. Hair clipped from collar treated dogs and cats, collected at various time
points, was used to assess the acaricidal efficacy of the actives ex vivo.
Results: An in vitro isolated insect nerve model demonstrated the synergistic neurotoxic effects of the pyrethroid
flumethrin and the neonicotinoid imidacloprid. An in vitro glass vial efficacy and mortality study against various life
stages of the ticks Ixodes ricinus, Rhipicephalus sanguineus and Dermacentor reticulatus and against the flea
(Ctenocephalides felis) demonstrated that the combination of these products was highly effective against these
parasites. The release kinetics of these actives from a neck collar (compounded with 10% imidacloprid and 4.5%
flumethrin) was extensively studied in dogs and cats under laboratory and field conditions. Acaricidal
concentrations of the actives were found to be consistently released from the collar matrix for 8 months. None of
the collar studies in dogs or cats were associated with any significant collar related adverse event.
Conclusion: Here we demonstrated the synergism between the pyrethroid flumethrin and the neonicotinoid
imidacloprid, both provided in therapeutically relevant doses by a slow release collar matrix system over 8 months.
This collar is therefore a convenient and safe tool for a long-term protection against ectoparasites.
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The control of ectoparasites is crucial in the prevention
of various vector-borne diseases that cause high morbid-
ity and in some cases mortality in dogs and cats. Some of
these infections are zoonoses and hence ectoparasite con-
trol on dogs and cats has become a major concern [1-5].
Ticks are second only to the mosquito as a means of dis-
ease transmission in humans and the most important
vector of vector-borne disease in dogs [6]. Pet travel is
now commonplace and as such many vector borne dis-
eases cross borders causing diseases atypical of their tra-
ditional geographic distribution with the result that many
dog tick borne diseases are now recognised as emerging
disease threats [1]. Over the last few decades several new
tick-borne infections have been identified and others are
regarded as re-emerging diseases (especially in dogs) [1].
Acaricides and insecticides have typically been applied as
dips and rinses, shampoos, powders, systemically admi-
nistered tablets, spot ons, sprays and chemically impreg-
nated collars [7].
The ideal ectoparasiticide product would be one with a
broad acaricidal and insecticidal activity, would contain
an active ingredient or combination of ingredients that
are non-toxic to pets, humans and the environment,
would be easy and simple to administer and would have
a very long residual action. Break down in ectoparasite
control strategies occur frequently and one of the most
common reasons for this is poor owner compliance caus-
ing disruption and sporadic use of control measures.
There is some work to show just how poor owner com-
pliance actually is in the care of the veterinary patient
[8-12]. Interestingly enough, there is only one study that
assesses owner compliance with regard to the use of
ectoparasiticides [13]. In this study where 1271 dogs
were evaluated for tick and flea preventative data,
approximately 74% of dogs were being treated with a tick
and flea control product and only 61% used these pro-
ducts year round. 138 cats were evaluated for the use of
tick and flea preventative. Only 38% of this cat popula-
tion were using tick and flea preventatives, with 47%
using a product year round and 34% using a product sea-
sonally. The use of products was varied according to sea-
son with owners being more diligent during what they
perceived as being the high risk seasons [13]. In some
countries (where there are distinct seasons) disease trans-
mission is seasonal but in the areas of the world with
more temperate climates or in the subtropical or tropical
regions, disease transmission is a year round problem. It
has been shown that the simpler a treatment protocol is,
the more likely an owner is to comply [11]. Poor owner
compliance has also been seen as possibly due to veteri-
narians relying increasingly on broad spectrum anti-para-
sitic drugs and very short consultations. This results in
poor client education which is an important factor
resulting in poor client compliance [14]. This trend is all
the more reason why products used should be easy to
apply and robust in efficacy in the hands of pet owners
who are unlikely to be given consistent and clear gui-
dance from a veterinarian in regards to ectoparasite con-
trol [13,14]. Acaricide and insecticide impregnated
collars have been widely used in an attempt to simplify
the administration of ectoparasiticides in dogs and cats
[15-18].
The pyrethroid flumethrin has been registered for ani-
mal use as an acaricide since 1986. Its pharmacological
activity is mediated through voltage gated sodium chan-
nels in neural tissue which it causes to remain open for
longer than physiologically normal, thus extending the
period of sodium influx [19]. The effect will only be seen
in stimulated tissue; resting tissue is unaffected by the
compound. Once stimulation occurs however, the result is
repeated shorter or longer bursts of nerve impulse result-
ing in death of the organism [20]. It has minimal effect on
mammals as it shows a high specificity for invertebrate
neural tissue. It has been extensively used in livestock as
an acaricide but is also registered for use in a collar pre-
paration in combination with propoxur [18]. Imidacloprid,
discovered in 1984, is a highly effective insecticide and has
become the largest selling insecticide worldwide for agri-
cultural and veterinary use in the last decade [21]. It has
its pharmacological action at the insect nicotinic acetyl-
choline receptor (nAChR) on the post synaptic membrane
where it interferes with neurotransmission by causing pro-
longed opening of the sodium channel resulting in sus-
tained depolarization of the neuron and death [21]. It is
highly insect specific in this action and has minimal effect
on the mammalian nAChR [22,23]. Imidacloprid has been
registered for use in dogs and cats as a spot on product
[21]. It is also available in combination with permethrin
(also a pyrethroid) for spot on use in dogs [24].
This report demonstrates the use of a unique active
ingredient combination of imidacloprid (10%) and flume-
thrin (4.5%) which show significant synergism in an in
vitro isolated insect nerve study and in a glass vial effi-
cacy and mortality study with various tick species and
fleas. The formulation of imidacloprid and flumethrin in
a collar matrix proved safe to dogs and cats and resulted
i nav e r yp r o l o n g e dr e l e a s eo fb o t hc o m p o u n d sw h i c h
indicates that pet owner compliance could be made sig-
nificantly more simple with a single collar application
lasting as long as 8 months.
Methods
Care of experimental animals
Laboratory based studies which were the source of the
collars used for the release kinetics investigations were
conducted at two sites (Bayer Animal Health, Leverku-
sen, Germany) and ClinVet International (Pty) Ltd.,
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compliance with Good Clinical Practice (GCP) and/or
Good Laboratory Practice (GLP) and in compliance with
the standards and norms of international legislation in
regards to animal use and care. Animals were either iden-
tified by permanent tattoo or subcutaneously placed
microchip transponders. All animals were adequately
acclimatised before entering a study. All animals were fed
commercial rations and had their health status checked
by a veterinarian before and during all trials. The efficacy
results of these studies are reported by Stanneck [25,26].
The field studies were conducted as multicentre dog and
cat studies in multiple veterinary clinics in Germany,
France, Hungary and Portugal. The field studies were con-
ducted in compliance with Good Clinical Practice and in
compliance with the standards and norms of international
and national legislation for field studies. Animals were liv-
ing in their normal household environments as pets and
had been presented to the study veterinarians for health
care. Their participation was voluntary. All animals had
their health status checked by a veterinarian before and
during the studies. The efficacy and safety results of these
studies are reported by Stanneck [27].
Synergism between flumethrin and imidacloprid
Whole cell voltage clamp measurements on isolated neuron
cells from spodoptera frugiperda
Whole cell voltage-clamp electrophysiological recordings
were performed on isolated neuronal cell bodies obtained
from Spodoptera frugiperda larval ganglia after enzymatic
treatment and mechanical dissociation. The ganglia were
treated with 0.002 g/L dispase (GIBCO BRL 17105-041),
incubated for 5 min at 37°C, centrifuged, and resuspended
in culture buffer (based on supplemented Leibowitz L-15
medium (Invitrogen 11415064) (for details see [28]) by
gentle aspiration with a fire-polished pasteur pipette (Hil-
genberg, Malsfeld Germany), with slight modifications as
described elsewhere [29]. Cell somata were plated onto
glass cover slips previously coated with concanavalin-A
(400 μg/ml, Sigma C2010) and laminin (4 μg/ml, Sigma
L2020). The cells were kept at room temperature. Electro-
physiological recordings were done with the whole-cell
voltage and current clamp technique as described else-
where [30]. The external bath contained Ringer’s solution
(in mM): 150 NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, 10 HEPES
(pH 7.4 adjusted with NaOH). The (internal) pipette solu-
tion contained (in mM): 120 CsF, 30 CsCl, 10 Cs-EGTA, 1
CaCl2, 10 HEPES (pH 7.4 adjusted with CsOH). Com-
pounds were applied to the cells using the U-tube reversed
flow technique [31]. Imidacloprid and flumethrin were
synthesised in house. The test compounds were freshly
dissolved as a 10 mM stock solution in DMSO (Sigma
D8418) and diluted to the required concentrations in
Ringer’s solution before the experiment. Currents were
measured with an L/M-EPC 7 patch clamp amplifier (List,
Darmstadt, Germany). Current records were low-pass Bes-
sel filtered at 1 kHz and digitized at 3 kHz sample rate for
measurements on voltage gated Na
+ channels.
Extracellular recording of spike activities on isolated nerve
cords from spodoptera frugiperda
Abdominal ganglia with a length of the associated distal
nerve cord were prepared from Spodoptera frugiperda
larvae and placed into a two-part plexi-glass chamber
filled with Ringer Solution (in mM: 150 NaCl, 4 KCl, 2
CaCl2, 2 MgCl2, 10 HEPES, pH 7,4). The gap between
the chambers was sealed with petroleum gel (Vaseline
®).
The caterpillar ganglia prepared in this way could be
used for two hours for electrophysiological experiments.
To monitor spike activity in the nerve cord, the voltage
difference between the two chambers was measured with
a differential amplifier (DAM-50, World Precision Instru-
ments, Berlin, Germany). Whenever an action potential
propagated along one of the axons in the nerve cord
under the petroleum gel barrier, a transient biphasic
potential of a few tens of microvolts could be measured
between the two chambers. These signals were viewed on
an oscilloscope and recorded through a digitizing inter-
face (PowerLab, AD Instruments, Spechbach, Germany)
into a PC running the PowerLab Chart Recording soft-
ware. Sample recordings were taken as screenshots from
the computer monitor and pasted into the figures. Spike
counts were obtained with the frequency counter feature
of the Chart Recording Software. A threshold was set
arbitrarily to recognize distinct spike activity in the first
baseline recording, and the counter was then viewed dur-
ing the replay of the recordings for the entire experiment.
In the recording chamber, the ganglion was bathed in
Ringer Solution. Drug solutions were applied by rapidly
exchanging the solution in the chamber (volume: 800 μl)
and allowing the drug to diffuse into the ganglion for 3-5
minutes. Washout was done by exchanging the chamber
volume twice in succession with Ringer’s solution. Flu-
methrin and imidacloprid were synthesized in house. Flu-
methrin was dissolved as a 10 mM stock solution in
DMSO (Sigma, D8418) and freshly diluted in 1:10 in
DMSO to enable the required test concentrations in
Ringer’s solution with a final DMSO concentration of 1%
before an experiment. Imidacloprid solutions were pre-
pared from the 10 mM DMSO stock solution and diluted
to the required test concentrations in Ringer’s solution.
In vitro evaluation of the efficacy of imidacloprid -
flumethrin combination against ticks and fleas
Imidacloprid flumethrin coated glass vial preparation
Glass vials for both tick and flea studies were prepared as
follows: Compound was dissolved in acetone p.A. (Merck
KGaA, no. 1.00014.1000, 99.8%) and diluted in the same
solvent. 3 × 250 μl of each compound dilution was
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vials (25 ml snap-on lid flask ND22, 65 × 26 mm, Fisher-
brand, art. no. 320 55 60) with an acetone-primed pip-
ette. Vials were placed on a Test-Tube Rotator (Rock ‘n’
Roller, model L-202, Labinco BV, NL) at 10 rpm and 5
rocking cycles per minute for at least 2 hours at room
temperature under a fume hood. Acetone was allowed to
dry off leaving a homogeneous coating of active on the
glass vial walls and bottom. The total surface area of the
glass vial was 44.7 cm
2. With 250 μlf r o ma9 0 0p p m
solution approximately 5 μg of active were applied per
cm
2.W h e r et h et w oi n g r e d i e n t sw e r eu s e di nc o m b i n a -
tion, the dose rate of the more highly concentrated active
was 900 ppm. The second ingredient was added at a
lower dose according to the mix ratio required (here 1.85
parts imidacloprid: 1 part flumethrin). Thus, at 900 ppm
imidacloprid, flumethrin was present at 486 ppm. The
ratio of 1.85:1 imidacloprid:flumethrin was chosen as this
was what was found to be the ratio of these two com-
pounds in animals hair coat during hair coat kinetic stu-
dies performed using these compounds in a slow release
collar device (see later).
Coated glass vial contact assay against ctenocephalides
felis
A d u l tm a l ea n df e m a l ec a tf l e a s( Ctenocephalides felis)
from a laboratory colony susceptible to neonicotinoids
and synthetic pyrethroids (adapted to breeding in an in-
vitro feeding system but also reared on colony cats) and
not more than 5 days post emergence were used. Fleas
were kept at room temperature and 80% relative humid-
ity until sorting and use in the experiments.
A portion of the fleas were anesthetized for 3-5 seconds
with CO2 and approximately 10 adult male and female
fleas of random gender ratio were transferred to each vial
as soon as they were fully immobilized. Vials were closed
with an untreated snap cap with needle-punctured holes
in the centre. Vials were kept at ambient temperature and
humidity horizontally to ensure maximum contact
between fleas and glass vial surface.
All original test data (represented as means from two
experiments) were analysed for statistical difference by
means of a paired two-tailed t-test after being tested for
normality. Significance was set at p < 0.05.
After 24 and after 48 hours flea activity was moni-
tored after gently tapping the vials on a hard surface.
Vials where all fleas showed normal occasional jumps
and coordinated movements were evaluated as zero effi-
cacy. Fleas with uncoordinated movements or fleas that
lay on one side showing only weak leg movements were
counted as alive despite the fact that they would not be
capable of infesting or feeding on a host. Fleas not mov-
ing at all after stimulation by tapping the vial were
counted as dead. Untreated and solvent treated control
vials served as controls.
Coated glass vial contact assay against various life stages
of ticks ixodes ricinus, rhipicephalus sanguineus and
dermacentor reticulatus
Assays against all three life stages (larvae, nymphs and
adults) were conducted for I. ricinus and R. sanguineus
whilst D. reticulatus larvae and adults were evaluated in
this glass vial contact study. In all cases laboratory colo-
nies were used at least 14 days post emergence. All ticks
were kept at room temperature and 90% relative humid-
ity until sorting and use. Ixodes ricinus and Dermacentor
reticulatus developmental stages were also kept at 90%
relative humidity throughout the incubation period of
the coated vials.
Five active adult ticks, 10 nymphs (no nymphs were
available from D. reticulatus) or approximately 25 larvae
were selected and transferred to each glass vial (vials were
prepared as described previously). Vials were closed with
an untreated snap cap with needle punctured holes in the
centre. Vials were stored horizontally and in the dark to
avoid movement of ticks onto the untreated lid.
After 24 and 48 hours ticks were forced to the bottom of
the glass vials by gently tapping the vials on a hard surface.
Unlike fleas, ticks tend not to move voluntarily and hence
a temperature stimulus at a temperature triggering typical
tick heat avoidance behaviour was used to evaluate their
viability: Glass vials were transferred onto a heating table
(at 45-50°C) for a maximum of 15 minutes. No more than
3 vials were handled at any one time. Vials where all ticks
showed normal heat avoidance and coordinated move-
ment were evaluated as having zero efficacy. Ticks with
slow heat avoidance and uncoordinated movements or
absent heat avoidance and poor leg and/or mouthpart
movement were counted as knock-down ticks (judged
incapable of normal host seeking and feeding). Ticks not
moving at all and not stimulated by an additional carbon
dioxide pulse were regarded as dead. Only mortality
counts were used in this study. Ticks from untreated and
solvent treated control vials served as controls. All original
mortality test data were analysed for statistical difference
by means of a paired two-tailed t-test after being tested for
normality. The Wilcoxon Signed Rank Test was used if
the probability of normality was below 0.05. Significance
for both tests was set at p <0 . 0 5 .
Release of active ingredients over time
Weight loss of collars over time
The release of active ingredients from the collar as evalu-
ated by collar weight change was studied in both cats and
dogs. Two collar sizes were used. A small collar (38 cm
l o n g )u s e di nc a t s ,a n di nd o g sw e i g h i n g8k go rl e s s .A
large collar (70 cm) was used in dogs weighing more
than 8 kg. A total of 177 dogs were collared under
laboratory conditions across 11 different studies and 59
dogs were collard under field conditions in a single study
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dies involved 9 laboratory based studies including 157
animals and a single field study involving 66 animals
(thus totalling 223 cats). Collars were evaluated over a
period of 240 days. Both dog and cat collars contained
the same amount of active ingredients (imidacloprid 10%
and flumethrin 4.5%; on a per collar weight basis 1 g of
collar contained 101 mg imidacloprid and 45 mg flume-
thrin). Collars were weighed once they had been trimmed
to size and the application weight was used as the base
line weight against which all changes in weight were
measured. In this way the change in collar weight could
be calculated based on weight loss over time.
Surface content of actives on the collar over time
The surface content of actives on collars compounded
with 10% imidacloprid and 4.5% flumethrin was evaluated
at various time points after they had been worn by cats.
All cats were European short hair breed that entered the
trial at 2 years and 32 months of age. Weights varied
between 3.3 and 5.1 kg on entry to the study. Three
laboratory housed cats per group (6 groups in total) were
fitted with a collar and after a period of 2, 7, 14, 28, 56 and
84 days the collars were removed for analysis. All collars
were weighed before application and upon removal. The
detection and quantification of the active ingredients imi-
dacloprid and flumethrin on the surface of the collars was
performed as follows: a piece of collar was placed in a sui-
table flask and agitated in a solvent mixture (acetonitrile
and water (8:2) for a defined time on a rotary shaker.
Actives were detected and quantified by HPLC using gra-
dient elution (acetonitrile and water with 0.01%TFA) on a
150*4.6 mm stainless steel column, packed with 4 μm
RP18 material. For detection a UV-spectrophotometer at
268 nm was used. Quantification was calculated against an
external standard. The surface release was calculated in
mg/g of collar.
Release of active ingredients over time
Weight loss of the collars is not a true reflection of the
release of the active ingredients alone but also will be
partially due to loss inert components such as plastici-
zers. For determination of the active ingredient released
over time, 177 randomly chosen collars that had been
worn for different time periods (up to 8 months) by cats
and dogs in various efficacy and target animal safety stu-
dies as well as in field studies were analysed to determine
their remaining active ingredient content. The determi-
nation of active ingredients in the collar body was per-
formed by HPLC after complete dissolution of the collar
in tetrahydrofuran (THF) and removal of plastics via pre-
cipitation by acetonitrile. HPLC was then performed as
described above. The amount of active ingredient
remaining in the collar was calculated against the nom-
inal start content of both active ingredients in the collar.
Acaricidal efficacy of cat and dog hair over time
The acaricidal activity of the actives on hair harvested
from dogs and cats in long term hair coat kinetics stu-
dies was investigated (Bayer Animal health study ID
35642 and ID 35643, unpublished data). Hair was har-
vested from 8 dogs and 8 cats that were wearing 10%
i m i d a c l o p r i d / 4 . 5 %f l u m e t h r i nc o l l a r s .H a i rs a m p l e sw e r e
collected with scissors (cutting as close to the skin as
possible) from the animals’ lateral left and right thoracic
region on days 7, 14, 21, 30, 59, 90, 120, 149, 181, 210
and 240. From each of these eleven time points, a repre-
sentative hair sample was selected which had a flume-
thrin content nearest to the group mean at the time
point. This reduced inter-individual variability. 0.1 gram
of each sample (left and right side) was weighed out,
mixed together and placed in individually marked Petri
dishes (diameter 6 cm). Samples of the same animals
were taken at two pre-treatment time points and served
as negative untreated controls. A total of 6 adult unfed
Rhipicephalus sanguineus ticks (3 male and 3 female)
originating from the Bayer colony were counted into
glass vials three days before the test and kept in an
incubator at a temperature of approximately 25°C and a
relative humidity of 70-80% until the test day. On the
test day the content of one vial was placed into each
Petri dish. The Petri dishes were incubated under the
same conditions until examination. After a contact time
of 4 h, 6 h, 12 h and 24 h the number of dead ticks,
moribund ticks, ticks with uncoordinated movements
and live ticks were counted. If the differentiation was
not possible with the naked eye, a stereomicroscope and
a heating plate (temperature 40 ± 5°C) was used for
detailed examination. Efficacy was determined by com-
parison of the live tick counts after each of the different
contact times and compared to the control samples
taken before treatment. The percent efficacy was calcu-
lated according to the recommendations for controlled
tests described in the guideline EMEA/CVMP/005/00-
Final [32]
% Efﬁcacy = (N2 − N1)/N2 × 100
N1 = number of ticks(treatment failure) in the group
treated with IVP
N2 = Number of ticks (treatment failure) in the pre-
treatment samples
Two versions of efficacy were calculated:
1) Killing efficacy was calculated using dead or mori-
bund ticks (treatment was regarded as a failure if all
ticks were found alive or in a moribund state).
2) Overall efficacy was calculated using all dead,
moribund and uncoordinated/ataxic ticks (treatment
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alive).
Results
Mode of action of pyrethroids on the insect Na
+ channel.
Demonstration of the"use dependent” effect of pyrethroids
On the insect nerve cell preparation from Spodoptera,
flumethrin bound preferentially to the open (activated)
state of the Na
+-channel and acted to keep the channel
open as shown in Figure 1a and 1b. Application of 10
μM flumethrin had almost no effect on the resting
nerve cell when the Na
+ channels were closed (as repre-
sented by the space between the arrows). Only after
channel opening, induced by a single short current
pulse (mean open time < 2 ms, each downward arrow
representing a pulse) could flumethrin bind to the chan-
nel and prevent channel closing (i.e. the channels modi-
fied by flumethrin stayed open), which caused an
increase of the membrane current. This demonstrated
the “use dependent” effect of pyrethroids.
Mode of action of imidacloprid on insect nAChR
The agonist effect of imidacloprid on insect nAChR is
shown in Figure 2. Application of 0.1 μM imidacloprid
opened the nAChRs and induced an inward current
under voltage clamp conditions (Figure 2a). This
inward current caused a depolarisation in the current
clamp mode (Figure 2b). This depolarisation activated
the Na
+-channels, which are the origin of action
potentials.
Demonstration of the synergistic effect of imidacloprid
on the flumethrin action in vitro at the level of isolated
nerve cord fibers
Figure 3 illustrates a typical experiment on the Spodoptera
nerve cord preparation. The baseline activity for a Spodop-
tera ganglion at rest usually showed a low level of sponta-
neous spike activity. In the example illustrated in Figure
3a it was 3 counts per second (cps, upper trace) as mea-
sured by the differential voltage recordings. After applica-
tion of a low concentration (100 nM) of imidacloprid, the
activity increased within 2-3 minutes, to a higher level of
constant activity (58 cps, Figure 3b). This effect was rever-
sible, and the initial baseline activity was again seen within
5-10 minutes after the wash-out of the test compound
(Figure 3c). In contrast to imidacloprid, 50 nM flumethrin
by itself had no significant effect on the nerve cord activity
(5 cps, Figure 3d). Finally, the combination of both com-
pounds induced a higher activity (89 cps) than the sum of
Figure 1 The use dependent effect of flumethrin. Figure 1a illustrates the three states of the voltage-gated sodium channel (closed, open
and inactivated). Flumethrin binds preferentially to the open state of the Na-channel and keeps the channel open as indicated by the
experiment shown in Figure 1b: In this experiment, flumthrin is applied (10 μM, green bar) to an isolated insect nerve cell in the whole cell
voltage clamp configuration (holding potential Vc = -100 mV, Na
+ channels closed). During the experiment 20 short current pulses (downward
arrows, every 1250 ms) were applied to change the holding potential from -100 mV to -10 mV to activate the voltage-gated Na channels (the
thin downward lines reflect the Na currents induced by opening of the Na channels). Because flumethrin caused a downward change in the
membrane current after Na
+ channel opening only and not during the much longer resting phase, this experiment clearly demonstrated the
use-dependent effect of flumethrin. (Figure 1a modified from: reference [33]).
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(b). Imidacloprid (left graph) induces an ion current for the whole time of application (see bar). After termination of the application the current
declines rapidly and returns to the resting level. No depolarization of the cell arises because the membrane potential was clamped by the
recording electrodes. In the current clamp mode (right graph) imidacloprid application induces a depolarization of the cell membrane, which
triggers the generation of many action potentials.
Figure 3 The synergistic effect of imidacloprid and flumethrin in isolated nerve cord fibres of Spodoptera frugiperda. The low baseline
spike activity is shown in (a). After the addition of 100 nM of imidacloprid spike activity increased to 58 counts per second (cps). Following
washout of the imidacloprid spike activity reduced to 4 cps as shown in (c). The addition of 50 nM of flumethrin alone induced a spike activity
of 5 cps (d). The combination of flumethrin and imidacloprid induced a dramatic increase of spike activity to 89 cps (e).
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(Figure 3e).
The results from five independent experiments are
summarized in Table 1. Flumethrin (50 nM) alone had
negligible effect on the nerve cord activity (5-10 cps)
with the exception of one experiment in which the
nerve cord activity was increased to 40 cps. Imidacloprid
(100 nM) alone increased the nerve cord activity to 50-
80 cps. In four of five experiments the combination of
both compounds together induced a higher activity (80-
100 cps) than the sum of the activities induced by either
of the compounds alone.
Coated glass vial contact assay
Two trials were conducted and the mean % mortality
and efficacy against Ctenocephalides felis of flumethrin
alone or imidacloprid alone or a 1:1.85 combination of
flumethrin and imidaclopridc o a t i n go ng l a s sv i a ls u r -
faces were evaluated. Test concentrations of the two
compounds were decreased in a step-wise fashion but in
the case of the combination, the ratio of the two com-
pounds was kept constant. The combined data and
curve fit statistics are provided in Table 2 and the dose
response curve for mortality of the combination of the
two compounds at 24 hours is illustrated in Figure 4. In
summary, it can be said that under the conditions of the
coated glass vial contact assay, efficacy against Ctenoce-
phalides felis was found to be superior in a 1: 1.85 mix-
ture of flumethrin: imidacloprid over the efficacy of
either active alone when considering mortality at 24
hours. Efficacy after 24 hours and efficacy as well as
mortality after 48 hours were comparable for flumethrin
alone or in combination with imidacloprid. Imidacloprid
alone showed slightly poorer performance at 24 hrs in
this dry surface in-vitro contact assay system.
At 24 hrs imidacloprid induced flea mortality in this
dry surface contact test was just significantly different
from the control group (p = 0.0457), the flumethrin
group (p = 0.004) and the combination treatment with
1:1.85 flumethrin: imidacloprid (p = 0.0028). The combi-
nation treatment was also significantly different from
the imidacloprid (p = 0.0024) and flumethrin (p =
0.0094) single treatments. The flumethrin treatment was
also significantly different from the Imidacloprid treat-
ment (p = 0.0027) thus supporting the synergistic effect
found in the electrophysiological measurements on iso-
lated insect neurons.
Figures 5, 6 and 7 show that the effect of stage depen-
dent susceptibility to the 1: 1.85 flumethrin: imidaclo-
prid mixtures is most pronounced for the mortality
curves after 24 hrs for all tick species tested. With
Ixodes ricinus the slopes of the curves were shallower
and adults show similar susceptibility as nymphs. For
Dermacentor reticulatus only larvae and adults were
tested. While larval susceptibility and adult mortality did
not change significantly between 24 and 48 hours incu-
bation time, adult mortality did increase.
It may thus be concluded that the 1: 1.85 flumethrin:
imidacloprid mixture produced mortality curves that
varied dependent on the tick life stage and tick species
tested although significant mortality was achieved
throughout at biologically relevant compound concen-
trations. Comparing tick species mortality curves of the
same developmental stage after treatment with of the 1:
1.85 flumethrin: imidacloprid mixture it may be con-
cluded that in general Dermacentor reticulatus larvae
and adults were more susceptible to the 1: 1.85 flume-
thrin: imidacloprid mixture than Ixodes ricinus (all life
stages) followed by Rhipicephalus sanguineus (all life
stages) under the conditions of this trial.
Table 1 The results of 5 independent experiments are summarised
Trial 100 nM Imidacloprid 50 nM Flumethrin 100 nM Imidacloprid + 50 nM Flumethrin Synergism
Trial Amp[μV] cps Amp[μV] cps Amp[μV] cps
05-05 75 75 - 5 150 100 ++
21-05a 50 58 - 5 100 89 ++
21-05b 50 75 - 10 70 100 ++
25-05a 50 80 10 40 100 90 +/-
25-05b 70 50 - 10 100 80 ++
mean 59 67.1 - 14 104 91.8
SD 12.45 12.9 - 14.75 28.81 8.44
P* [vs combination of Flu/Imi] 0.009 0.003 na 0.0007 - -
The isolated nerve cord fibres of Spodoptera frugiperda were stimulated with 100 nM imidacloprid, 50 nM flumethrin and then a combination of these two
compounds and the amplitude of nerve discharge and the number of discharges (counts per second, cps) are given. Imidacloprid alone had a modest effect,
flumethrin alone had a negligible effect and the combination of both compounds together demonstrate a clearly synergistic effect well in excess of what either
compound alone induced
* Normality and two-sided paired t-test was perfomed for all data from five trials using SigmaPlot for Windows 11.0 (Build 11.0.0.75,
© 2008 Systat Software, Inc.)
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from the controls (control mortality zero throughout the
trial in all species) regardless of tick species or develop-
mental stage (p < 0.001). Considering the mortality data of
Rhipicephalus sanguineus,l a r v a ew e r em o r es u s c e p t i b l e
than adults (p = 0.006) and nymphs (p = 0.021), and
nymphs were more susceptible than adults (p =0 . 0 2 1 ) .
The Ixodes mortality curves of nymphs and larvae were
not significantly different from each other (p =0 . 2 0 1 ) .
Ixodes ricinus adults were less susceptible than nymphs (p
= 0,034) and larvae (p = 0.034). Most pronounced was the
difference between adult and larval Dermcentor reticulatus
mortality (p < 0,001).
Weight loss of collars over time
The percentage weight loss of the collars over time in
the cat studies are reflected in Table 3. The percentage
of weight loss of the collars over time in the dog studies
are reflected in Table 4. Summary data is provided in a
dot plot in Figure 8.
Surface content on the collar over time
Results of the surface analysis immediately after collar
removal at various time points after collar fitting show
that both active ingredients were present on the surface
of the collars worn by cats over the whole investigation
period. By day 2 the imidacloprid surface content was at
approximately 9-12% of the starting collar content, and
decreased slightly to 6-8% of the starting content by day
84. There was a relatively broad scattering of the surface
content of imidacloprid over the time period of study.
The content of flumethrin on the surface of the worn
collars was, however, relatively constant during the
study with a slight increase by day 14 which then pla-
teaued at around 2% until day 84 (Figure 9).
Release of active ingredients over time
Determining the remaining content of active ingredients
in the collar over time and the amount of active ingredi-
ents released from the collar provided the best indication
of the kinetics of release of the compounds from the col-
lar matrix over the duration of the study. These data
were calculated as relative remaining amount [%] com-
pared to the initial starting amount of both active ingre-
dients and given as mean values per study (Table 5).
They were further re-calculated as relative collar content
a n da r es h o w ni nad o tp l o ti nF i g u r e1 0f o rb o t ha c t i v e
ingredients.
Table 2 The dose response curve showing mean % mortality and efficacy of flumethrin or imidacloprid or a 1: 1.85
combination of flumethrin and imidacloprid coating on glass vial surfaces (mean data from 2 separate trials) against
Ctenocephalides felis fleas
Imidacloprid: Flumethrin 1.85: 1 Flumethrin Imidacloprid
[μg/cm
2] 24 h 48 h 24 h 48 h 24 h 48 h
Mortality Efficacy Mortality Efficacy Mortality Efficacy Mortality Efficacy Mortality Efficacy Mortality Efficacy
5 100 100 100 100 75 100 100 100 30 100 100 100
1 100 100 100 100 60 100 80 100 25 90 100 100
0,2 80 100 100 100 40 100 70 100 0 60 80 100
0,04 40 80 60 100 30 60 60 100 0 30 40 100
0,008 0 30 30 60 0 0 0 40 0 0 0 0
0,0016 0 0 0 0 0 0 0 0 0 0 0 0
0,00032 0 0 0 0 0 0 0 0 0 0 0 0
0,000064 0 0 0 0 0 0 0 0 0 0 0 0
min -1,582 -2,287 -0,078 -0,011 -4,929 -1,243 -3,390 0,031 -1,531 -0,914 -1,752 -0,012
max 100,5 100,4 103,8 100,0 100,0 99,9 93,7 100,0 100,0 101,0 106,0 100,0
ED50 μg/cm
2 0,059 0,012 0,033 0,008 0,483 0,010 0,039 0,009 0,537 0,074 0,112 0,017
Slope 1,296 1,285 1,111 3,889 0,363 1,736 1,031 4,006 17,378 1,433 0,937 3,315
ED50 Factor (FI = 1) 8,2 0,9 1,2 1,2 9,1 6,4 3,4 2,3
Normality* Test
(Shapiro-Wilk)
Passed Passed Passed Passed Passed Passed Passed Passed Passed Failed Passed Passed
P-values* 24 h
mortality vs
untreated control
0.028 0.004 0.0457
P-values* FI vs F or I - 0.0094 -0.0024
P-values* F vs I - - -0.0027
* Normality and two-sided paired t-test was perfomed for data used in Figure 4 with all data from both trials, means of the two trials were used for curve fitting
and fit statistics using SigmaPlot for Windows 11.0 (Build 11.0.0.75,
© 2008 Systat Software, Inc.)
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cloprid and flumethrin to beyond 8 months at which
time the collars contained approximately 60% (imidaclo-
p r i d )a n d8 0 %( f l u m e t h r i n )o ft h es t a r tc o n c e n t r a t i o n .
The collar applications were well tolerated in all cats
and dogs and no clinical signs of disease or adverse
effects besides mild mechanical effects were noted when
collars were applied correctly.
Acaricidal efficacy of cat and dog hair over time
All control ticks on 100% of the untreated hair samples
were alive, healthy and showed normal behaviour for
the duration of the incubation period. In contrast to
this, all hair samples collected from cats and dogs trea-
ted with the collar over the period of 8 months caused
pronounced tick mortality. After 4 hrs of contact time
ticks appeared generally disorientated and showed ataxic
movements but no acaricidal efficacy was observed.
After 6 hrs of contact time 97.9% of the ticks were dead
or moribund, 0.5% of the ticks showed ataxic or uncoor-
dinated movement whilst only 1.7% of the ticks were
alive and appeared normal. This was also true after 8
hrs of contact time. After 12 hrs of contact time 99.8%
ticks were dead or moribund, 0.2% of the ticks were
Figure 4 Dose response curves of flea mortality for flumethrin or imidacloprid or a 1: 1.85 combination of flumethrin and
imidacloprid. The dose response curves show mean % mortality after 24 hours contact against Ctenocephalides felis on glass vial surfaces
treated with different doses of flumethrin, imidacloprid or a 1: 1.85 combination of flumethrin and imidacloprid (mean data from 2 separate
trials; curves including 95% confidence interval as dashed lines calculated with SigmaPlot for Windows 11.0 (Build 11.0.0.75,
© 2008 Systat
Software, Inc.).
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Page 10 of 18Figure 5 Dose response curves for flumethrin: imidacloprid (1: 1.85) mortality against Ixodes ricinus life stages in coated glass vial
contact assays. a) Dose response curves after 24 hours contact time. b) Dose response curves after 48 hours contact time. Note: The curves
include the 95% confidence interval as dashed lines calculated with SigmaPlot for Windows 11.0 (Build 11.0.0.75,
© 2008 Systat Software, Inc.).
Figure 6 Dose response curves for flumethrin: imidacloprid (1: 1.85) mortality against Rhipicephalus sanguineus life stages in coated glass
vial contact assays. a) Dose response curves after 24 hours contact time. b) Dose response curves after 48 hours contact time. Note: The curves
include the 95% confidence interval as dashed lines calculated with SigmaPlot for Windows 11.0 (Build 11.0.0.75,
© 2008 Systat Software, Inc.).
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Page 11 of 18ataxic. Finally, after 24 hrs of contact time all ticks were
dead or moribund, making the 48 hr evaluation
meaningless.
The results of a single experiment representing the 6
hr (which were unchanged at 8 hrs) and 12 h (which
w e r eu n c h a n g e da t4 8h r s )e v a l u a t i o na r ep r e s e n t e di n
Table 6.
Discussion
Pharmacologic synergism is not a new concept and may
be defined as the combined effect of two (or more) sub-
stances that have a significantly greater effect than the
effects of the individual substances used independently
[34]. Pharmacological synergism was in fact first described
in ectoparasiticides [35,36] but is also widely appreciated
in antimicrobial therapy [37] and in cancer chemotherapy
[38]. Flumethrin and imidacloprid have never previously
been used together in a single preparation for ectoparasite
control in dogs and cats. Both compounds have a neuro-
pharmacological excitatory effect but through differing
molecular mechanisms and it may be speculated, based on
their pharmacological mechanism of action that they
would act synergistically against fleas and ticks. Neural cell
membrane sodium channels are present in three different
states: closed, open, and inactivated (Figure 1a). Flume-
thrin preferentially binds to the open state channel and
then keeps the channel open resulting in a state of persis-
tent depolarization. A low dose of imidacloprid would
activate nicotinic acetylcholine receptors (nAChR) chan-
nels inducing an inward flow of current causing depolari-
zation of the cell and activating (thus opening) sodium
channels thus theoretically making them significantly
more susceptible to the excitatory (and hence toxic) effects
of flumethrin.
The initial investigation made use of an in vitro isolated
insect nerve study. At rest, the isolated Spodoptera frugi-
perda ganglia usually show a low level of spontaneous
spike activity of between 3 and 25 counts per second (cps).
This rate increases dramatically when compounds that are
known to increase the excitability of the neurons by acti-
vating of nAChR, such as imidacloprid, are applied. In
contrast to this, flumethrin does not increase the activity
of an almost silent nerve bundle, which could be plausibly
explained by the fact that pyrethroids bind preferentially
to open sodium channels (i.e. an activated neuron) and
therefore will have no or little effect on a resting neuron
(at least at the low concentrations used in this study). It is
known that in insects the pyrethroid insecticides (such as
flumethrin) bind preferentially to the open (activated)
sodium channel and once bound keep the channel open
[39]. The action of pyrethroids is thus described as ‘use
dependant’ in that they have little effect on resting nerve
cells but a marked effect on stimulated cells. A low dose of
imidacloprid activates nAChR channels and increases the
frequency of the nerve cell electrical spiking. This trans-
lates into more sodium channels being open thus allowing
flumethrin far better interaction with its target. Thus, as
we have shown here, the application of both compounds
together leads to a much higher level of activity than either
compound alone, which demonstrates that neonicotinoid
insecticides (such as imidacloprid) acting on the nAChr
and pyrethroid insecticides acting on voltage dependent
sodium channels cooperate at the level of the insect ner-
vous system to produce an enhanced sensitivity to the pyr-
ethroid component, providing a way to obtain similar
levels of pest control with a reduced dose of pyrethroid.
This is a classical (albeit new) example pharmacological
synergism.
The next phase of the study investigated whether this
principle would be visible in a well-controlled in vitro
tick and flea study. The glass vial (dry surface) efficacy
studies were conducted as an in vitro measure of flea and
tick sensitivity to the flumethrin and imidacloprid and
their combination. Using an in vitro system prior to
assessment in an in vivo system provides accurate and
repeatable data on the effect of the active compounds
Figure 7 Dose response curves for flumethrin: imidacloprid (1:
1.85) mortality against Dermacentor reticulatus stages in
coated glass vial contact assays. Mortality dose response curves
after 24 and 48 hours contact time. Note: The curves include the
95% confidence interval as dashed lines calculated with SigmaPlot
for Windows 11.0 (Build 11.0.0.75,
© 2008 Systat Software, Inc.).
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trolled factors that a dog or cat skin and hair coat would
add. What the in vitro isolated Spodoptera frugiperda
ganglia studies showed in respect of the synergistic
effects of imidacloprid and flumethrin was observed in
this glass vial study on the whole living tick and flea
organism. Although the in vitro Spodoptera nerve study
demonstrated the synergism was true in an insect system,
the efficacy studies conducted in the glass vial system
indicated that the combination product exerted very high
activities against ticks as well with Dermacentor and
Ixodes being the most sensitive species followed by Rhipi-
cephalus sanguineus.
Having demonstrated that the theory of pharmacologi-
cal synergism holds true in an isolated insect nerve
study and against the ticks and fleas in a glass vial sys-
tem, the next phase of the study reported here evaluated
the behaviour of the active ingredients in a collar matrix
application device. The advantage of a collar system is
the ease of application for an owner (enhancing compli-
ance) and the potential for continuous slow release of
the actives onto the dog or cats coat over an extended
period of time (encouraging owner compliance further).
The first way of evaluating this was through simply
monitoring weight loss of the collar over time. The col-
lars lost between 15 and 18% of their weight on the
Table 3 The percentage weight loss of collars in the cat studies over time
Bayer Animal Health study member Breed (body weight [kg]) Study duration [days] mean weight loss [%]
146.164 Mix (2.3-5.4) 30 10,7
238 20,1
146.303 DSH (3.7-4.7) 238 18.5
146.159 Mix (2.1-4.7) 60 8,4
152.152 DSH (2.8-5.3) 61 9.1
152.150 DSH (0.86-1.47) SD 0 30 5,04
60 7,10
146.747 DSH (3.6-5.7) 28 4.4
146.156 DSH (2.8-5.3) 238 19.1
146.045 DSH (3.8-7.0) 241 20.8
146.155 DSH (2.7- 240 18.8
146.162 (field) several (1.7-8.3) up to 240 days time depending
Small collars were used in a total of 157 cats in laboratory based studies plus 66 cats in a field study. DSH: domestic short haired
Table 4 The percentage weight loss of collars in the dog studies over time
Bayer Animal Health study number Breed (body weight [kg]) Study duration [days] mean weight loss [%]
146.165 Mix (11.6-19.4) 30 18.1
238 5.4
146.306 Beagle (9.4-13.6) 238 17.8
146.161 Mix (8.4-20.2) 60 4.2
152.151 Beagle (8.7-13.4) 61 7.9
152.149 Beagle (1.5-2.9) SD 0 23 3,4
30 6.5
60 13.5
146.737 Beagle (8.7-11.7) 28 3.2 and 2.9
146.158 Beagle (8.8-12.8) 245 14.8
146.390 Beagle (6.6-20-4) 240 16.0
146.592 Beagle (8.3-13.5) 240 17.7
146.269 Mix (7.1-21.5) 90 8.3
146.607 Beagle (10.0-13.1) 91 9.7
146.163 (field) collar S (n = 48; of 45 dogs): several breeds (0.5-8 kg) up to 240 days time depending
collar L (n = 242; of 219 dogs): several breeds (8-69 kg) time depending
Large collars were used in all the laboratory based animals totalling 177 animals plus 59 field study animals. Of these, 48 used large collars and the remainder
used small collars.
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cats when worn over the full period for which insectici-
dal and acaricidal amounts of the actives are released (8
months). The fastidious grooming behaviour of cats
could explain the slightly increased weight loss of the
collar on the cat compared to the dog. Grooming beha-
viour would remove actives from the coat and result in
a higher concentration gradient and hence faster collar
reload of the coat in the cat than the dog.
The next way to evaluate the release kinetics of the
actives from the collar was to evaluate the concentration
of the actives on the surface of the collar at various time
points. The results of the surface concentration of the
active ingredients over time demonstrated an effective
surface reload onto the collar surface that allowed for a
reload of the actives down a concentration gradient from
the collar surface to the animal’sc o a t .R e s u l t so ft h es u r -
face analysis immediately after collar removal at various
time points after collar fitting showed that approximately
2% of the starting flumethrin content in the collar is pre-
sent on the collar surface for the 8 month study duration.
The actives on the surface of the collar are constantly
Figure 8 Weight loss of collars in cat and dog studies as calculated at various time points over the duration of the study. The weight loss
is presented as % of the starting weight. 223 cat collars and 236 dog collars were included. Single unusually high values reflect chewed collars.
Figure 9 Surface content of imidacloprid and flumethrin on the surface of collars after being worn for various periods of time.T h e
figure reflects the removable surface content on the collar surfaces worn by cats for 2, 7, 14, 28, 56, and 84 days. 3 collars were tested per time
point.
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equilibrium is established between actives in the collar,
on the collar surface and on the animal’s coat. The imida-
cloprid on the surface of the collars decreased slightly
o v e rt h e8 4d a y so ft h es t u d yf r o m9 - 1 2 %o ft h es t a r t i n g
collar content, to 6 - 8% at day 84, which suggests that
removal of the active ingredient down the concentration
gradient from the collar to the surface to the animal’s
hair coat is slightly faster than what the collar releases as
actives onto its surface. These results are supported by
the analysis of the concentrations of the actives in the
collar over time. The change in concentration of the
active ingredients in the collar matrix over the duration
of the collar application in dogs and cats indicated a
steady decrease due to a release of the active compounds
for a time period slightly in excess of eight months. By
the termination of the experiments (at 8 months) collars
contained approximately 60% of their starting imidaclo-
prid content and 80% of their flumethrin starting con-
tent. This reflects a continuous concentration gradient
between the collar and the coat and a continuous coat
reload of the actives from the collar for the 8 months of
collar application. To substantiate a claim of efficacy of 8
months, the amount of active ingredients remaining in
the collar at 8 months should still result in a sufficient
concentration gradient between collar and animal surface
to allow for steady release and biological efficacy for
another several months beyond the claim. When evaluat-
ing efficacy against ticks and fleas in the real life situation
in the numerous studies reported by Stanneck [25,26]
there was a decrease in efficacy, however, to below a 90%
(for ticks) or 95% (for fleas) after 8 months. This is
reflected in the product’s registered label claim. This
apparent contradiction (a drop in efficacy to below
threshold) despite adequate collar concentrations of the
active compounds) reflects the delicate balance of the
physical and -chemical environments at play in such a
long-term collar release matrix. These factors are influ-
enced by numerous variables and as such are much more
complex than the factors in play in the application of an
active in a single-application fluid system such as with a
spot on.
Table 5 The remaining percentage (± standard deviation) of the imidacloprid and flumethrin start amount in 177
collars worn by laboratory cats and dogs for different durations
Bayer Animal Health Study number No. of animals Wearing time [days] mean % of initial amount
Imidacloprid Flumethrin
CAT STUDIES = small collar
ID 35118 3 2 94.6 ± 0.67 99.7 ± 0.79
3 7 89.6 ± 0.48 98.3 ± 0.44
3 14 85.5 ± 4.32 97.0 ± 1.25
3 28 81.7 ± 1.32 97.7 ± 0.75
3 56 72.6 ± 2.61 95.0 ± 0.22
3 84 70.9 ± 1.81 91.7 ± 2.27
ID 35638 8 30 79.7 ± 2.95 97.0 ± 0.64
ID 33697 30 60 77.7 ± 8.30 92.5 ± 3.13
ID 35121 8 238 74.7 ± 4.53 81.6 ± 5.39
ID 35635 10 241 61.4 ± 2.50 72.7 ± 2.52
ID 35632 10 240 57.9 ± 3.27 85.6 ± 2.28
ID 35630 9 238 59.7 ± 3.12 84.9 ± 2.23
mean cat 8 months 37 238-240 59.7 ± 3.0 81.9 ± 6.0
DOG STUDIES = large collar
ID 35637 8 30 81.7 ± 2.23 96.5 ± 2.97
ID 33692 32 60 79.1 ± 4.62 97.7 ± 2.71
ID 33691 10 90 74.7 ± 4.53 81.6 ± 5.39
ID 35117 6 91 72.0 ± 2.32 88.8 ± 5.92
ID 35631 10 245 60.5 ± 3.96 80.8 ± 5.44
ID 35120 8 238 62.4 ± 6.21 70.4 ± 3.47
ID 35636 10 240 68.7 ± 2.03 80.8 ± 7.40
Mean dog 8 months 28 238-245 64.0 ± 5.40 77.8 ± 7.2
Mean total 8 months 65 238-245 61.6 ± 4.70 80.1 ± 6.9
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combination of imidacloprid and flumethrin and evalua-
tion of the behaviour of these actives in the collar, an
experiment evaluated the efficacy of hair clipped from
dogs and cats wearing the collar against ticks and fleas.
It has been known for many years now that the concen-
tration of imidacloprid achieved on the coat of spot on
treated animals is effective up until the end of the 4
th
week after application (the duration for which efficacy is
claimed). Keeping the levels in the coat achieved by the
spot on product in mind, we assumed that because the
levels achieved by the collar device described here were
never below those achieved by the spot on (for 8
months), the collar delivered imidacloprid dose would
remain effective for this period. Topical flumethrin has
long been known to be an effective acaricide, but the
hair coat concentrations for efficacy are unknown. It has
previously been established that it does not work sys-
temically as topically applied compound is below the
limit of detection in the blood of topically treated ani-
mals (Bayer Animal Health registration study ID 35642
and ID 35643, unpublished data). Taken together these
unpublished results necessitated an in vitro study that
evaluated the efficacy of hair harvested from dogs and
cats treated with the imidacloprid: flumethrin collar
device. Special attention was given to efficacy at very
early time points (starting at 4 hours post collar applica-
tion). Preventing tick attachment is crucial to preventing
Figure 10 Decrease of imidacloprid and flumethrin collar content over time. The figure describes the decrease of the relative imidacloprid
and flumethrin collar content in 177 collars worn by 93 cats and 84 dogs for different durations during laboratory studies.
Table 6 The 6 and 12 hour incubation efficacy of hair coat samples of dogs and cats wearing imidacloprid 10%/
flumethrin 4.5% collars for 8 months, on adult Rhipicephalus sanguineus ticks
Sampling day = Day after treatment 7 14 21 30 59 90 120 149 181 210 240
killing
1
efficacy
cat [%] 6 hours 100 83 100 100 100 100 100 67 33 0 50
dog[%] 100 67 100 83 100 100 100 100 100 100 83
overall
2
efficacy
cat [%] 100 83 100 100 100 100 100 67 33 100 50
dog[%] 100 100 100 100 100 100 100 100 100 100 83
killing
1
efficacy
cat [%] 12 hours 100 100 100 100 100 100 100 100 83 100 100
dog[%] 100 100 100 100 100 100 100 100 100 100 100
overall
2 efficacy cat [%] 100 100 100 100 100 100 100 100 100 100 100
dog[%] 100 100 100 100 100 100 100 100 100 100 100
1 killing efficacy was calculated from ticks being dead or moribund
2 overall efficacy was calculated from ticks being dead or moribund + atactic ticks
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Page 16 of 18disease transmission. Including ticks that show abnor-
mal behaviour that would prevent them from normal
attachment and feeding, hair harvested from collar trea-
ted dogs and cats showed an efficacy of 99.3% after 6
hours and 100% after 12 hours (and hence for any time
point thereafter for the duration of 8 months). These
results strongly support a non-systemic, obviously exter-
nal mode of action over the period of 8 months and
provide evidence of very rapid repellent acaricidal effi-
cacy which has also been reported from numerous other
on animal studies [25-27,40]. This is the longest time
period for which a collar impregnated with an acaricide
and an insecticide together has ever been shown to be
capable of providing therapeutically relevant concentra-
tions of active ingredients from its surface to the coat of
a dog or cat.
Conclusions
In conclusion, we have been able to demonstrate a
unique pharmacological synergism between 10% imida-
cloprid and 4.5% flumethrin. This synergism was shown
in an in vitro isolated insect nerve study and in an in
vitro glass vial study using various tick life stages in var-
ious tick species and in fleas. The release kinetics of the
active ingredients from the collar were also evaluated
a n di tw a sf o u n dt h a tt h e r a p e u t i c a l l yr e l e v a n td o s e so f
both imidacloprid and flumethrin were released from
the collar for 8 months. Hair harvested from collar trea-
ted dogs and cats showed a very early (6 hours) repel-
lent activity that would prevent ticks from attaching and
feeding, thus minimizing the opportunity a tick would
have to attach, feed and transmit disease. This is the
longest a collar device has ever shown this release
kinetic. The 8 month long duration of efficacy after a
very simple collar application greatly simplifies the pet
owner’s task of ectoparasite control in a world where
owner compliance is resoundingly poor. This is largely
due to limited veterinary instruction and the relatively
intensive managemental responsibility placed on owners
for frequent product applications all year around in
environments where vector borne diseases are not
declining but are rather an increasing threat to both ani-
mal and human health.
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